advertisement
11.14 Investigational drugs; pharmacological experiments (21)
Showing records 1 to 21
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments53973 Ethyl pyruvate treatment mitigates oxidative stress damage in cultured trabecular meshwork cells
Famili A; Ammar DA; Kahook MY
Molecular Vision 2013; 19: 1304-1309
53825 Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells
Thomasy SM; Morgan JT; Wood JA; Murphy CJ; Russell P
Experimental Eye Research 2013; 113: 66-73
53533 Synthesis and biological evaluation of urea derivatives as highly potent and selective rho kinase inhibitors
Yin Y; Lin L; Ruiz C; Khan S; Cameron MD; Grant W; Pocas J; Eid N; Park H; Schröter T; Lograsso PV; Feng Y
Journal of Medicinal Chemistry 2013; 56: 3568-3581
53708 Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio
Kernt M; Arend N; Buerger A; Mann T; Haritoglou C; Ulbig MW; Kampik A; Hirneiss C
Journal of Glaucoma 2013; 22: 404-412
53856 An Effective Prodrug Strategy to Selectively Enhance Ocular Exposure of a Cannabinoid Receptor (CB1/2) Agonist
Mainolfi N; Powers J; Amin J; Long D; Lee W; McLaughlin ME; Jaffee B; Brain CT; Elliott J; Sivak JM
Journal of Medicinal Chemistry 2013; 0:
53523 Targeting the A3 adenosine receptor for glaucoma treatment (review)
Fishman P; Cohen S; Bar-Yehuda S
Molecular medicine reports 2013; 7: 1723-1725
54004 Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension
Sandalon S; Könnecke B; Levkovitch-Verbin H; Simons M; Hein K; Sättler MB; Bähr M; Ofri R
Experimental Eye Research 2013; 115: 47-56
53977 Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice
Howell GR; Soto I; Ryan M; Graham LC; Smith RS; John SW
Journal of Neuroinflammation 2013; 10: 76
53903 Intravitreal cidofovir injection for the management of chronic glaucoma in dogs
Low MC; Landis ML; Peiffer RL
Veterinary Ophthalmology 2014; 17: 201-206
53780 Effect of intranasal budesonide irrigations on intraocular pressure
Seiberling KA; Chang DF; Nyirady J; Park F; Church CA
International forum of allergy & rhinology 2013; 3: 704-707
53500 Effects of thailanstatins on glucocorticoid response in trabecular meshwork and steroid-induced glaucoma
Jain A; Liu X; Wordinger RJ; Yorio T; Cheng YQ; Clark AF
Investigative Ophthalmology and Visual Science 2013; 54: 3137-3142
53933 Nerve growth factor: basic studies and possible therapeutic applications
Manni L; Rocco ML; Bianchi P; Soligo M; Guaragna M; Barbaro SP; Aloe L
Growth Factors 2013; 31: 115-122
53472 Dynamic mobilization of PGC-1α mediates mitochondrial biogenesis for the protection of RGC-5 cells by resveratrol during serum deprivation
Chen S; Fan Q; Li A; Liao D; Ge J; Laties AM; Zhang X
Apoptosis 2013; 18: 786-799
53695 Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo
Carta F; Akdemir A; Scozzafava A; Masini E; Supuran CT
Journal of Medicinal Chemistry 2013; 56: 4691-4700
53778 Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Investigative Ophthalmology and Visual Science 2013; 54: 4296-4306
53553 Randomized, Double-Masked, Placebo-Controlled Study to Assess the Ocular Safety of Mirabegron in Healthy Volunteers
Novack GD; Lewis RA; Vogel R; Sheth N; Swearingen D; Rasmussen S; Hantsbarger G; Martin NE
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 674-680
54058 Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma
Yao BQ; Pang YY; Li YX
Chinese Journal of Ophthalmology 2013; 49: 340-344
53948 Phase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
JAMA ophthalmology 2013; 0: 1-8
53559 Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
Journal of Pharmacology and Experimental Therapeutics 2013; 346: 138-145
54052 Role of dopaminergic receptors in glaucomatous disease modulation
Pescosolido N; Parisi F; Russo P; Buomprisco G; Nebbioso M
BioMed research international 2013; 2013: 193048
53924 Rho-associated kinase inhibitors: A novel glaucoma therapy
Inoue T; Tanihara H
Progress in Retinal and Eye Research 2013; 37: 1-12
